A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
Clinical trial NCT07262268 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07262268
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-15
- Primary completion
- 2026-11-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.